As of 2025-07-11, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -10.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 430.66 mil USD. TMCI's TTM EBITDA according to its financial statements is -42.95 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 25.1x | 21.7x |
| Forward P/E multiples | 23.8x - 28.3x | 25.3x |
| Fair Price | (16.92) - (17.79) | (16.68) |
| Upside | -372.4% - -386.5% | -368.7% |
| Date | EV/EBITDA |
| 2025-07-10 | -10.03 |
| 2025-07-09 | -10.04 |
| 2025-07-08 | -9.95 |
| 2025-07-07 | -9.79 |
| 2025-07-03 | -9.98 |
| 2025-07-02 | -9.85 |
| 2025-07-01 | -9.75 |
| 2025-06-30 | -9.54 |
| 2025-06-27 | -9.35 |
| 2025-06-26 | -9.12 |
| 2025-06-25 | -9.68 |
| 2025-06-24 | -9.60 |
| 2025-06-23 | -9.34 |
| 2025-06-20 | -9.00 |
| 2025-06-18 | -8.93 |
| 2025-06-17 | -8.90 |
| 2025-06-16 | -9.37 |
| 2025-06-13 | -9.24 |
| 2025-06-12 | -9.53 |
| 2025-06-11 | -9.97 |
| 2025-06-10 | -9.97 |
| 2025-06-09 | -9.57 |
| 2025-06-06 | -9.44 |
| 2025-06-05 | -9.38 |
| 2025-06-04 | -9.38 |
| 2025-06-03 | -9.44 |
| 2025-06-02 | -9.34 |
| 2025-05-30 | -9.34 |
| 2025-05-29 | -9.51 |
| 2025-05-28 | -9.50 |
| 2025-05-27 | -9.85 |
| 2025-05-23 | -9.54 |
| 2025-05-22 | -9.87 |
| 2025-05-21 | -10.14 |
| 2025-05-20 | -10.73 |
| 2025-05-19 | -10.79 |
| 2025-05-16 | -10.77 |
| 2025-05-15 | -10.82 |
| 2025-05-14 | -10.77 |
| 2025-05-13 | -11.15 |
| 2025-05-12 | -11.47 |
| 2025-05-09 | -10.92 |
| 2025-05-08 | -11.97 |
| 2025-05-07 | -11.48 |
| 2025-05-06 | -11.74 |
| 2025-05-05 | -11.65 |
| 2025-05-02 | -11.56 |
| 2025-05-01 | -11.68 |
| 2025-04-30 | -11.30 |
| 2025-04-29 | -11.26 |